CancerConnect is a leading developer of consumer focused educational content on all aspects of cancer. Cancer Connect programs are used by leading oncology care providers and information destinations including large cancer centers such as Dana-Farber Cancer Institute, The Ohio State James Cancer Institute, The University of New Mexico, and Memorial Sloan-Kettering Cancer Center, as well as leading oncology physicians’ practices like Texas Oncology to improve patient education and engagement on their websites. Cancer Connect produces daily cancer news, in depth disease state content and interactive programs like Ask The Expert.
OMNI Health Media (OMNI) was established in 1996 and is a leading multi-media publisher of health-related information produced specifically for consumers. Each month, OMNI’s content, which focuses on women’s health and wellness, cancer, rheumatoid arthritis, and GI health reaches over 1.5 million people through its print and digital platforms.
OMNI’s digital platforms include AWomansHealth.com, the companion website for Women; TheArthritisConnection.com, a site devoted to rheumatoid arthritis and its treatments; TheGIConnection.com, devoted to gastrointestinal health topics; and CancerConnect.com, an oncology information resource center and social network portal for cancer patients and their caregivers. OMNI also produces the “Understanding Cancer” video series, featuring “Web Chats with the Experts.”
Across all OMNI platforms, our goal is to provide comprehensive, accurate, evidence-based information about health to help consumers make informed decisions about their health and wellness.
Content planning for print and online platforms is based on our mission to deliver current, relevant, and reputable information. Content selection and creation is governed by the following criteria:
- Clinical and Scientific Accuracy: Content is vetted for medical and scientific accuracy by medical professionals and includes references, to allow readers to pursue further research.
- Relevance: Topics for print and online publication are selected based on their relevance for consumers, highlighting current topics of research and discussion to provide our audience background, sources, and expert and patient insight to help them make informed decisions about their health.
OMNI editorial content is subject to a stringent review process wherein articles are reviewed by medical editors to ensure the accuracy and timeliness of all information.
OMNI editorial content is written either by our staff medical writers, staff oncologists or by other independent physicians, healthcare professionals or health writers whom we commission. We require that writers reference current peer-reviewed medical journals, when applicable, and that they cite those references accurately within the text of the article. When the sources in an article are other than peer-reviewed journals, those sources are also referenced and cited within the article. Only appropriately-credentialed medical professionals are quoted within editorial content. Content is independently reviewed by staff editors for accuracy and appropriate references.
Conflict of Interest/Ethics Policy
OMNI staff editors and writers and contracted writers are required to disclose any financial investments in or involvement with any health-related company that may be the subject of editorial content that the individual is writing or editing. If there is even the possibility of a conflict of interest, the story is reassigned to another writer or editor.
Links to Other Resources
Any links provided within OMNI content are provided solely as a service to consumers. These links do not indicate an endorsement or recommendation on our part.